Product Information

SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $5.0394 per EA under NDC 43598061860. Its NADAC has been published 110 times since May 22, 2024.

SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET

Saxagliptin and Metformin Hydrochloride
$5.0394per EA

Strength

1000; 2.5 mg/1; mg/1

NDC

43598061860

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207678

On Market Since

8/9/2023

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET has been published 110 times since May 22, 2024, and over the history we have for it it has risen 7.7%. The table below summarizes its recorded NADAC range and movement.

Current price$5.0394 per EA
All-time high$5.1601 (Nov 12, 2025)
All-time low$4.1869 (Sep 18, 2024)
52-week high$5.1601
52-week low$4.5490
Median price$4.6351
Average price$4.6433
Largest weekly change+12.3% (Oct 23, 2024)
Weeks tracked110
Tracking sinceMay 22, 2024

Price History

1W

0.0%

1M

+0.7%

3M

+7.6%

6M

+3.2%

1Y

+8.7%

3Y

N/A

5Y

N/A

All

+7.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Saxagliptin and Metformin Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $5.0394 per EA (NDC 43598061860), effective Jun 24, 2026.

How has the price of SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET changed over time?

Over the history we have for it, the NADAC for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET has risen 7.7%. It has been tracked across 110 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET?

Since May 22, 2024, the NADAC for SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET has ranged from a low of $4.1869 (Sep 18, 2024) to a high of $5.1601 (Nov 12, 2025), with a median of $4.6351 per EA.

Are there cheaper alternatives to SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET?

SAXAGLIPTIN-METFORMIN ER 2.5-1,000 MG TABLET (NDC 43598061860) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.